nodes	percent_of_prediction	percent_of_DWPC	metapath
Saquinavir—SLCO1A2—epilepsy syndrome	0.102	0.269	CbGaD
Saquinavir—CYP11A1—epilepsy syndrome	0.0885	0.235	CbGaD
Saquinavir—ABCC2—epilepsy syndrome	0.0486	0.129	CbGaD
Saquinavir—ABCG2—epilepsy syndrome	0.043	0.114	CbGaD
Saquinavir—CYP2C19—epilepsy syndrome	0.0338	0.0896	CbGaD
Saquinavir—CYP2D6—epilepsy syndrome	0.0251	0.0664	CbGaD
Saquinavir—ALB—epilepsy syndrome	0.0187	0.0497	CbGaD
Saquinavir—ABCC2—Levetiracetam—epilepsy syndrome	0.0184	0.0441	CbGbCtD
Saquinavir—ABCB1—epilepsy syndrome	0.0179	0.0474	CbGaD
Saquinavir—ABCC1—Phenobarbital—epilepsy syndrome	0.0114	0.0274	CbGbCtD
Saquinavir—ABCC2—Carbamazepine—epilepsy syndrome	0.0105	0.0253	CbGbCtD
Saquinavir—ALB—Oxcarbazepine—epilepsy syndrome	0.0105	0.0251	CbGbCtD
Saquinavir—ABCC2—Phenytoin—epilepsy syndrome	0.00946	0.0227	CbGbCtD
Saquinavir—ALB—Fosphenytoin—epilepsy syndrome	0.00915	0.022	CbGbCtD
Saquinavir—SLC22A1—Midazolam—epilepsy syndrome	0.00884	0.0213	CbGbCtD
Saquinavir—ABCC2—Phenobarbital—epilepsy syndrome	0.00843	0.0203	CbGbCtD
Saquinavir—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00841	0.0202	CbGbCtD
Saquinavir—ALB—Clonazepam—epilepsy syndrome	0.00827	0.0199	CbGbCtD
Saquinavir—CYP2C8—Trimethadione—epilepsy syndrome	0.00752	0.0181	CbGbCtD
Saquinavir—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00707	0.017	CbGbCtD
Saquinavir—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00704	0.0169	CbGbCtD
Saquinavir—CYP3A7—Carbamazepine—epilepsy syndrome	0.00704	0.0169	CbGbCtD
Saquinavir—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00678	0.0163	CbGbCtD
Saquinavir—ALB—Rufinamide—epilepsy syndrome	0.00674	0.0162	CbGbCtD
Saquinavir—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00632	0.0152	CbGbCtD
Saquinavir—CYP3A7—Phenytoin—epilepsy syndrome	0.00632	0.0152	CbGbCtD
Saquinavir—CYP2C19—Felbamate—epilepsy syndrome	0.00631	0.0152	CbGbCtD
Saquinavir—CYP2C19—Trimethadione—epilepsy syndrome	0.00631	0.0152	CbGbCtD
Saquinavir—ABCB1—Levetiracetam—epilepsy syndrome	0.00599	0.0144	CbGbCtD
Saquinavir—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00593	0.0143	CbGbCtD
Saquinavir—ALB—Phenytoin—epilepsy syndrome	0.00589	0.0142	CbGbCtD
Saquinavir—CYP3A7—Phenobarbital—epilepsy syndrome	0.00563	0.0135	CbGbCtD
Saquinavir—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00563	0.0135	CbGbCtD
Saquinavir—CYP3A7—Midazolam—epilepsy syndrome	0.00555	0.0133	CbGbCtD
Saquinavir—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00555	0.0133	CbGbCtD
Saquinavir—ALB—Propofol—epilepsy syndrome	0.0055	0.0132	CbGbCtD
Saquinavir—CYP3A7—Diazepam—epilepsy syndrome	0.00534	0.0128	CbGbCtD
Saquinavir—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00534	0.0128	CbGbCtD
Saquinavir—CYP3A5—Carbamazepine—epilepsy syndrome	0.00528	0.0127	CbGbCtD
Saquinavir—CYP2C9—Trimethadione—epilepsy syndrome	0.00524	0.0126	CbGbCtD
Saquinavir—CYP2C19—Clobazam—epilepsy syndrome	0.00514	0.0124	CbGbCtD
Saquinavir—CYP2C8—Carbamazepine—epilepsy syndrome	0.00508	0.0122	CbGbCtD
Saquinavir—ALB—Diazepam—epilepsy syndrome	0.00498	0.012	CbGbCtD
Saquinavir—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00493	0.0118	CbGbCtD
Saquinavir—CYP2C8—Primidone—epilepsy syndrome	0.00474	0.0114	CbGbCtD
Saquinavir—CYP3A5—Phenytoin—epilepsy syndrome	0.00474	0.0114	CbGbCtD
Saquinavir—CYP2C8—Phenytoin—epilepsy syndrome	0.00455	0.0109	CbGbCtD
Saquinavir—CYP2C19—Carbamazepine—epilepsy syndrome	0.00426	0.0102	CbGbCtD
Saquinavir—CYP2C8—Propofol—epilepsy syndrome	0.00425	0.0102	CbGbCtD
Saquinavir—CYP3A5—Phenobarbital—epilepsy syndrome	0.00422	0.0101	CbGbCtD
Saquinavir—CYP3A5—Midazolam—epilepsy syndrome	0.00416	0.01	CbGbCtD
Saquinavir—ABCB1—Clobazam—epilepsy syndrome	0.00415	0.00997	CbGbCtD
Saquinavir—CYP2C8—Phenobarbital—epilepsy syndrome	0.00406	0.00976	CbGbCtD
Saquinavir—CYP3A5—Diazepam—epilepsy syndrome	0.004	0.00962	CbGbCtD
Saquinavir—ABCB1—Lamotrigine—epilepsy syndrome	0.00399	0.0096	CbGbCtD
Saquinavir—CYP2C19—Primidone—epilepsy syndrome	0.00398	0.00956	CbGbCtD
Saquinavir—CYP2C8—Diazepam—epilepsy syndrome	0.00385	0.00925	CbGbCtD
Saquinavir—CYP2C19—Phenytoin—epilepsy syndrome	0.00382	0.00918	CbGbCtD
Saquinavir—CYP2C19—Propofol—epilepsy syndrome	0.00356	0.00856	CbGbCtD
Saquinavir—CYP2C9—Carbamazepine—epilepsy syndrome	0.00354	0.00851	CbGbCtD
Saquinavir—ABCB1—Carbamazepine—epilepsy syndrome	0.00344	0.00826	CbGbCtD
Saquinavir—CYP2C19—Phenobarbital—epilepsy syndrome	0.00341	0.00818	CbGbCtD
Saquinavir—CYP2C9—Primidone—epilepsy syndrome	0.00331	0.00795	CbGbCtD
Saquinavir—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00328	0.00788	CbGbCtD
Saquinavir—CYP2C19—Diazepam—epilepsy syndrome	0.00323	0.00776	CbGbCtD
Saquinavir—CYP2C9—Phenytoin—epilepsy syndrome	0.00318	0.00763	CbGbCtD
Saquinavir—CYP3A5—Valproic Acid—epilepsy syndrome	0.00316	0.00758	CbGbCtD
Saquinavir—CYP2C19—Zonisamide—epilepsy syndrome	0.00315	0.00757	CbGbCtD
Saquinavir—ABCB1—Phenytoin—epilepsy syndrome	0.00308	0.00741	CbGbCtD
Saquinavir—CYP3A4—Felbamate—epilepsy syndrome	0.00305	0.00733	CbGbCtD
Saquinavir—CYP3A4—Trimethadione—epilepsy syndrome	0.00305	0.00733	CbGbCtD
Saquinavir—CYP2C8—Valproic Acid—epilepsy syndrome	0.00303	0.00729	CbGbCtD
Saquinavir—CYP2C9—Propofol—epilepsy syndrome	0.00296	0.00712	CbGbCtD
Saquinavir—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00287	0.00689	CbGbCtD
Saquinavir—CYP2C9—Phenobarbital—epilepsy syndrome	0.00283	0.0068	CbGbCtD
Saquinavir—ABCB1—Phenobarbital—epilepsy syndrome	0.00275	0.0066	CbGbCtD
Saquinavir—ABCB1—Midazolam—epilepsy syndrome	0.00271	0.00651	CbGbCtD
Saquinavir—CYP2D6—Propofol—epilepsy syndrome	0.00271	0.00651	CbGbCtD
Saquinavir—CYP2C9—Diazepam—epilepsy syndrome	0.00268	0.00645	CbGbCtD
Saquinavir—ABCB1—Diazepam—epilepsy syndrome	0.00261	0.00626	CbGbCtD
Saquinavir—CYP3A4—Clonazepam—epilepsy syndrome	0.00259	0.00623	CbGbCtD
Saquinavir—CYP2C19—Valproic Acid—epilepsy syndrome	0.00255	0.00612	CbGbCtD
Saquinavir—CYP3A4—Clobazam—epilepsy syndrome	0.00249	0.00597	CbGbCtD
Saquinavir—CYP2C19—Topiramate—epilepsy syndrome	0.0023	0.00552	CbGbCtD
Saquinavir—CYP2C9—Valproic Acid—epilepsy syndrome	0.00212	0.00509	CbGbCtD
Saquinavir—CYP3A4—Rufinamide—epilepsy syndrome	0.00211	0.00508	CbGbCtD
Saquinavir—CYP3A4—Carbamazepine—epilepsy syndrome	0.00206	0.00495	CbGbCtD
Saquinavir—CYP3A4—Primidone—epilepsy syndrome	0.00192	0.00462	CbGbCtD
Saquinavir—CYP3A4—Phenytoin—epilepsy syndrome	0.00185	0.00444	CbGbCtD
Saquinavir—CYP3A4—Propofol—epilepsy syndrome	0.00172	0.00414	CbGbCtD
Saquinavir—CYP3A4—Acetazolamide—epilepsy syndrome	0.00165	0.00396	CbGbCtD
Saquinavir—CYP3A4—Phenobarbital—epilepsy syndrome	0.00165	0.00396	CbGbCtD
Saquinavir—CYP3A4—Midazolam—epilepsy syndrome	0.00162	0.0039	CbGbCtD
Saquinavir—CYP3A4—Diazepam—epilepsy syndrome	0.00156	0.00375	CbGbCtD
Saquinavir—CYP3A4—Zonisamide—epilepsy syndrome	0.00152	0.00366	CbGbCtD
Saquinavir—CYP3A4—Valproic Acid—epilepsy syndrome	0.00123	0.00296	CbGbCtD
Saquinavir—CYP3A4—Topiramate—epilepsy syndrome	0.00111	0.00267	CbGbCtD
Saquinavir—Nelfinavir—SLCO1A2—epilepsy syndrome	0.000456	0.163	CrCbGaD
Saquinavir—Indinavir—SLCO1A2—epilepsy syndrome	0.000419	0.15	CrCbGaD
Saquinavir—Mitiglinide—KCNJ11—epilepsy syndrome	0.000376	0.135	CrCbGaD
Saquinavir—SLC22A1—ganglion—epilepsy syndrome	0.000323	0.0821	CbGeAlD
Saquinavir—Indinavir—ABCC2—epilepsy syndrome	0.0002	0.0716	CrCbGaD
Saquinavir—Nelfinavir—ABCG2—epilepsy syndrome	0.000193	0.069	CrCbGaD
Saquinavir—Lopinavir—CYP2C19—epilepsy syndrome	0.000163	0.0583	CrCbGaD
Saquinavir—Nelfinavir—CYP2C19—epilepsy syndrome	0.000152	0.0542	CrCbGaD
Saquinavir—CYP11A1—medulla oblongata—epilepsy syndrome	0.000142	0.036	CbGeAlD
Saquinavir—Indinavir—CYP2C19—epilepsy syndrome	0.000139	0.0498	CrCbGaD
Saquinavir—SLC22A1—forebrain—epilepsy syndrome	0.000136	0.0344	CbGeAlD
Saquinavir—SLCO1A2—forebrain—epilepsy syndrome	0.000131	0.0332	CbGeAlD
Saquinavir—SLC22A1—telencephalon—epilepsy syndrome	0.000125	0.0317	CbGeAlD
Saquinavir—Atazanavir—ABCB1—epilepsy syndrome	0.000121	0.0433	CrCbGaD
Saquinavir—Lopinavir—CYP2D6—epilepsy syndrome	0.000121	0.0432	CrCbGaD
Saquinavir—SLCO1A2—telencephalon—epilepsy syndrome	0.00012	0.0305	CbGeAlD
Saquinavir—Nelfinavir—CYP2D6—epilepsy syndrome	0.000112	0.0402	CrCbGaD
Saquinavir—CYP11A1—head—epilepsy syndrome	0.000112	0.0285	CbGeAlD
Saquinavir—CYP2D6—hindbrain—epilepsy syndrome	0.00011	0.0279	CbGeAlD
Saquinavir—CYP11A1—nervous system—epilepsy syndrome	0.000106	0.027	CbGeAlD
Saquinavir—Indinavir—CYP2D6—epilepsy syndrome	0.000103	0.0369	CrCbGaD
Saquinavir—CYP11A1—central nervous system—epilepsy syndrome	0.000102	0.026	CbGeAlD
Saquinavir—ABCC1—telencephalon—epilepsy syndrome	9.85e-05	0.025	CbGeAlD
Saquinavir—ORM1—spinal cord—epilepsy syndrome	9.54e-05	0.0242	CbGeAlD
Saquinavir—SLCO1A2—medulla oblongata—epilepsy syndrome	9.43e-05	0.024	CbGeAlD
Saquinavir—Lopinavir—ABCB1—epilepsy syndrome	8.63e-05	0.0309	CrCbGaD
Saquinavir—SLCO1A2—midbrain—epilepsy syndrome	8.62e-05	0.0219	CbGeAlD
Saquinavir—SLCO1A2—spinal cord—epilepsy syndrome	8.41e-05	0.0214	CbGeAlD
Saquinavir—ABCG2—telencephalon—epilepsy syndrome	8.16e-05	0.0207	CbGeAlD
Saquinavir—CYP11A1—brain—epilepsy syndrome	8.14e-05	0.0207	CbGeAlD
Saquinavir—ORM1—nervous system—epilepsy syndrome	8.04e-05	0.0204	CbGeAlD
Saquinavir—Nelfinavir—ABCB1—epilepsy syndrome	8.02e-05	0.0287	CrCbGaD
Saquinavir—SLC22A1—head—epilepsy syndrome	7.76e-05	0.0197	CbGeAlD
Saquinavir—ORM1—central nervous system—epilepsy syndrome	7.74e-05	0.0196	CbGeAlD
Saquinavir—SLCO1A2—head—epilepsy syndrome	7.48e-05	0.019	CbGeAlD
Saquinavir—Indinavir—ABCB1—epilepsy syndrome	7.37e-05	0.0263	CrCbGaD
Saquinavir—SLC22A1—nervous system—epilepsy syndrome	7.36e-05	0.0187	CbGeAlD
Saquinavir—SLCO1A2—nervous system—epilepsy syndrome	7.09e-05	0.018	CbGeAlD
Saquinavir—SLC22A1—central nervous system—epilepsy syndrome	7.09e-05	0.018	CbGeAlD
Saquinavir—SLCO1A2—central nervous system—epilepsy syndrome	6.82e-05	0.0173	CbGeAlD
Saquinavir—SLCO1A2—cerebellum—epilepsy syndrome	6.67e-05	0.0169	CbGeAlD
Saquinavir—ABCG2—medulla oblongata—epilepsy syndrome	6.41e-05	0.0163	CbGeAlD
Saquinavir—CYP2D6—brainstem—epilepsy syndrome	6.3e-05	0.016	CbGeAlD
Saquinavir—CYP2D6—forebrain—epilepsy syndrome	6.08e-05	0.0154	CbGeAlD
Saquinavir—ABCG2—midbrain—epilepsy syndrome	5.86e-05	0.0149	CbGeAlD
Saquinavir—ABCG2—spinal cord—epilepsy syndrome	5.71e-05	0.0145	CbGeAlD
Saquinavir—SLC22A1—brain—epilepsy syndrome	5.63e-05	0.0143	CbGeAlD
Saquinavir—CYP2D6—telencephalon—epilepsy syndrome	5.59e-05	0.0142	CbGeAlD
Saquinavir—ABCC1—cerebellum—epilepsy syndrome	5.47e-05	0.0139	CbGeAlD
Saquinavir—SLCO1A2—brain—epilepsy syndrome	5.42e-05	0.0138	CbGeAlD
Saquinavir—ALB—brain—epilepsy syndrome	5.39e-05	0.0137	CbGeAlD
Saquinavir—ABCG2—cerebellum—epilepsy syndrome	4.53e-05	0.0115	CbGeAlD
Saquinavir—ABCC1—brain—epilepsy syndrome	4.45e-05	0.0113	CbGeAlD
Saquinavir—ABCB1—forebrain—epilepsy syndrome	4.37e-05	0.0111	CbGeAlD
Saquinavir—ABCB1—telencephalon—epilepsy syndrome	4.02e-05	0.0102	CbGeAlD
Saquinavir—CYP2C8—brain—epilepsy syndrome	3.78e-05	0.00961	CbGeAlD
Saquinavir—ABCG2—brain—epilepsy syndrome	3.68e-05	0.00935	CbGeAlD
Saquinavir—CYP2D6—head—epilepsy syndrome	3.48e-05	0.00884	CbGeAlD
Saquinavir—CYP3A4—nervous system—epilepsy syndrome	3.35e-05	0.00852	CbGeAlD
Saquinavir—CYP2D6—nervous system—epilepsy syndrome	3.3e-05	0.00838	CbGeAlD
Saquinavir—CYP3A4—central nervous system—epilepsy syndrome	3.23e-05	0.0082	CbGeAlD
Saquinavir—CYP2D6—central nervous system—epilepsy syndrome	3.18e-05	0.00807	CbGeAlD
Saquinavir—ABCB1—medulla oblongata—epilepsy syndrome	3.16e-05	0.00803	CbGeAlD
Saquinavir—CYP2D6—cerebellum—epilepsy syndrome	3.11e-05	0.00789	CbGeAlD
Saquinavir—ABCB1—midbrain—epilepsy syndrome	2.89e-05	0.00733	CbGeAlD
Saquinavir—ABCB1—spinal cord—epilepsy syndrome	2.82e-05	0.00716	CbGeAlD
Saquinavir—CYP2D6—brain—epilepsy syndrome	2.52e-05	0.00641	CbGeAlD
Saquinavir—ABCB1—head—epilepsy syndrome	2.5e-05	0.00636	CbGeAlD
Saquinavir—ABCB1—nervous system—epilepsy syndrome	2.37e-05	0.00603	CbGeAlD
Saquinavir—ABCB1—central nervous system—epilepsy syndrome	2.29e-05	0.00581	CbGeAlD
Saquinavir—ABCB1—cerebellum—epilepsy syndrome	2.23e-05	0.00567	CbGeAlD
Saquinavir—Visual impairment—Topiramate—epilepsy syndrome	2.04e-05	0.000138	CcSEcCtD
Saquinavir—Arthralgia—Pregabalin—epilepsy syndrome	2.03e-05	0.000138	CcSEcCtD
Saquinavir—Chest pain—Pregabalin—epilepsy syndrome	2.03e-05	0.000138	CcSEcCtD
Saquinavir—Myalgia—Pregabalin—epilepsy syndrome	2.03e-05	0.000138	CcSEcCtD
Saquinavir—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.03e-05	0.000138	CcSEcCtD
Saquinavir—Dizziness—Zonisamide—epilepsy syndrome	2.03e-05	0.000138	CcSEcCtD
Saquinavir—Headache—Diazepam—epilepsy syndrome	2.03e-05	0.000138	CcSEcCtD
Saquinavir—Anxiety—Pregabalin—epilepsy syndrome	2.02e-05	0.000137	CcSEcCtD
Saquinavir—Diarrhoea—Clonazepam—epilepsy syndrome	2.02e-05	0.000137	CcSEcCtD
Saquinavir—Anaemia—Gabapentin—epilepsy syndrome	2.02e-05	0.000137	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.02e-05	0.000137	CcSEcCtD
Saquinavir—Hypotension—Valproic Acid—epilepsy syndrome	2.01e-05	0.000136	CcSEcCtD
Saquinavir—Asthenia—Carbamazepine—epilepsy syndrome	2.01e-05	0.000136	CcSEcCtD
Saquinavir—Agitation—Gabapentin—epilepsy syndrome	2.01e-05	0.000136	CcSEcCtD
Saquinavir—Diarrhoea—Phenytoin—epilepsy syndrome	2.01e-05	0.000136	CcSEcCtD
Saquinavir—Discomfort—Pregabalin—epilepsy syndrome	2.01e-05	0.000136	CcSEcCtD
Saquinavir—Nausea—Fosphenytoin—epilepsy syndrome	2e-05	0.000136	CcSEcCtD
Saquinavir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2e-05	0.000136	CcSEcCtD
Saquinavir—Erythema multiforme—Topiramate—epilepsy syndrome	2e-05	0.000135	CcSEcCtD
Saquinavir—Hypersensitivity—Lamotrigine—epilepsy syndrome	2e-05	0.000135	CcSEcCtD
Saquinavir—Vomiting—Felbamate—epilepsy syndrome	1.99e-05	0.000135	CcSEcCtD
Saquinavir—Dry mouth—Pregabalin—epilepsy syndrome	1.99e-05	0.000135	CcSEcCtD
Saquinavir—Pruritus—Carbamazepine—epilepsy syndrome	1.98e-05	0.000134	CcSEcCtD
Saquinavir—Rash—Felbamate—epilepsy syndrome	1.98e-05	0.000134	CcSEcCtD
Saquinavir—Eye disorder—Topiramate—epilepsy syndrome	1.98e-05	0.000134	CcSEcCtD
Saquinavir—Dermatitis—Felbamate—epilepsy syndrome	1.97e-05	0.000134	CcSEcCtD
Saquinavir—Malaise—Gabapentin—epilepsy syndrome	1.97e-05	0.000134	CcSEcCtD
Saquinavir—Tinnitus—Topiramate—epilepsy syndrome	1.97e-05	0.000134	CcSEcCtD
Saquinavir—Vertigo—Gabapentin—epilepsy syndrome	1.97e-05	0.000133	CcSEcCtD
Saquinavir—Headache—Felbamate—epilepsy syndrome	1.96e-05	0.000133	CcSEcCtD
Saquinavir—Confusional state—Pregabalin—epilepsy syndrome	1.96e-05	0.000133	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.96e-05	0.000133	CcSEcCtD
Saquinavir—Cardiac disorder—Topiramate—epilepsy syndrome	1.96e-05	0.000133	CcSEcCtD
Saquinavir—Syncope—Gabapentin—epilepsy syndrome	1.96e-05	0.000133	CcSEcCtD
Saquinavir—Leukopenia—Gabapentin—epilepsy syndrome	1.96e-05	0.000133	CcSEcCtD
Saquinavir—Dizziness—Clonazepam—epilepsy syndrome	1.96e-05	0.000133	CcSEcCtD
Saquinavir—Nausea—Vigabatrin—epilepsy syndrome	1.95e-05	0.000132	CcSEcCtD
Saquinavir—Vomiting—Zonisamide—epilepsy syndrome	1.95e-05	0.000132	CcSEcCtD
Saquinavir—Insomnia—Valproic Acid—epilepsy syndrome	1.95e-05	0.000132	CcSEcCtD
Saquinavir—Oedema—Pregabalin—epilepsy syndrome	1.95e-05	0.000132	CcSEcCtD
Saquinavir—Asthenia—Lamotrigine—epilepsy syndrome	1.94e-05	0.000132	CcSEcCtD
Saquinavir—Dizziness—Phenytoin—epilepsy syndrome	1.94e-05	0.000132	CcSEcCtD
Saquinavir—Rash—Zonisamide—epilepsy syndrome	1.93e-05	0.000131	CcSEcCtD
Saquinavir—Infection—Pregabalin—epilepsy syndrome	1.93e-05	0.000131	CcSEcCtD
Saquinavir—Paraesthesia—Valproic Acid—epilepsy syndrome	1.93e-05	0.000131	CcSEcCtD
Saquinavir—Dermatitis—Zonisamide—epilepsy syndrome	1.93e-05	0.000131	CcSEcCtD
Saquinavir—Dizziness—Oxcarbazepine—epilepsy syndrome	1.93e-05	0.000131	CcSEcCtD
Saquinavir—Nausea—Diazepam—epilepsy syndrome	1.92e-05	0.00013	CcSEcCtD
Saquinavir—Loss of consciousness—Gabapentin—epilepsy syndrome	1.92e-05	0.00013	CcSEcCtD
Saquinavir—Headache—Zonisamide—epilepsy syndrome	1.92e-05	0.00013	CcSEcCtD
Saquinavir—Dyspnoea—Valproic Acid—epilepsy syndrome	1.92e-05	0.00013	CcSEcCtD
Saquinavir—Diarrhoea—Carbamazepine—epilepsy syndrome	1.92e-05	0.00013	CcSEcCtD
Saquinavir—Angiopathy—Topiramate—epilepsy syndrome	1.92e-05	0.00013	CcSEcCtD
Saquinavir—Pruritus—Lamotrigine—epilepsy syndrome	1.92e-05	0.00013	CcSEcCtD
Saquinavir—Shock—Pregabalin—epilepsy syndrome	1.92e-05	0.00013	CcSEcCtD
Saquinavir—Somnolence—Valproic Acid—epilepsy syndrome	1.91e-05	0.00013	CcSEcCtD
Saquinavir—Immune system disorder—Topiramate—epilepsy syndrome	1.91e-05	0.000129	CcSEcCtD
Saquinavir—Nervous system disorder—Pregabalin—epilepsy syndrome	1.91e-05	0.000129	CcSEcCtD
Saquinavir—Cough—Gabapentin—epilepsy syndrome	1.91e-05	0.000129	CcSEcCtD
Saquinavir—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.91e-05	0.000129	CcSEcCtD
Saquinavir—Mediastinal disorder—Topiramate—epilepsy syndrome	1.91e-05	0.000129	CcSEcCtD
Saquinavir—Chills—Topiramate—epilepsy syndrome	1.9e-05	0.000129	CcSEcCtD
Saquinavir—Dyspepsia—Valproic Acid—epilepsy syndrome	1.9e-05	0.000128	CcSEcCtD
Saquinavir—Convulsion—Gabapentin—epilepsy syndrome	1.9e-05	0.000128	CcSEcCtD
Saquinavir—Skin disorder—Pregabalin—epilepsy syndrome	1.89e-05	0.000128	CcSEcCtD
Saquinavir—Hypertension—Gabapentin—epilepsy syndrome	1.89e-05	0.000128	CcSEcCtD
Saquinavir—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.88e-05	0.000128	CcSEcCtD
Saquinavir—Vomiting—Clonazepam—epilepsy syndrome	1.88e-05	0.000127	CcSEcCtD
Saquinavir—Decreased appetite—Valproic Acid—epilepsy syndrome	1.87e-05	0.000127	CcSEcCtD
Saquinavir—Alopecia—Topiramate—epilepsy syndrome	1.87e-05	0.000127	CcSEcCtD
Saquinavir—Vomiting—Phenytoin—epilepsy syndrome	1.87e-05	0.000127	CcSEcCtD
Saquinavir—Rash—Clonazepam—epilepsy syndrome	1.86e-05	0.000126	CcSEcCtD
Saquinavir—Dermatitis—Clonazepam—epilepsy syndrome	1.86e-05	0.000126	CcSEcCtD
Saquinavir—Chest pain—Gabapentin—epilepsy syndrome	1.86e-05	0.000126	CcSEcCtD
Saquinavir—Arthralgia—Gabapentin—epilepsy syndrome	1.86e-05	0.000126	CcSEcCtD
Saquinavir—Myalgia—Gabapentin—epilepsy syndrome	1.86e-05	0.000126	CcSEcCtD
Saquinavir—Nausea—Felbamate—epilepsy syndrome	1.86e-05	0.000126	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.86e-05	0.000126	CcSEcCtD
Saquinavir—Vomiting—Oxcarbazepine—epilepsy syndrome	1.86e-05	0.000126	CcSEcCtD
Saquinavir—Fatigue—Valproic Acid—epilepsy syndrome	1.86e-05	0.000126	CcSEcCtD
Saquinavir—Anxiety—Gabapentin—epilepsy syndrome	1.86e-05	0.000126	CcSEcCtD
Saquinavir—Anorexia—Pregabalin—epilepsy syndrome	1.86e-05	0.000126	CcSEcCtD
Saquinavir—Dizziness—Carbamazepine—epilepsy syndrome	1.85e-05	0.000126	CcSEcCtD
Saquinavir—Diarrhoea—Lamotrigine—epilepsy syndrome	1.85e-05	0.000126	CcSEcCtD
Saquinavir—Headache—Clonazepam—epilepsy syndrome	1.85e-05	0.000126	CcSEcCtD
Saquinavir—Rash—Phenytoin—epilepsy syndrome	1.85e-05	0.000126	CcSEcCtD
Saquinavir—Mental disorder—Topiramate—epilepsy syndrome	1.85e-05	0.000126	CcSEcCtD
Saquinavir—Dermatitis—Phenytoin—epilepsy syndrome	1.85e-05	0.000125	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.85e-05	0.000125	CcSEcCtD
Saquinavir—Rash—Oxcarbazepine—epilepsy syndrome	1.84e-05	0.000125	CcSEcCtD
Saquinavir—Constipation—Valproic Acid—epilepsy syndrome	1.84e-05	0.000125	CcSEcCtD
Saquinavir—Pain—Valproic Acid—epilepsy syndrome	1.84e-05	0.000125	CcSEcCtD
Saquinavir—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.84e-05	0.000125	CcSEcCtD
Saquinavir—Headache—Phenytoin—epilepsy syndrome	1.84e-05	0.000125	CcSEcCtD
Saquinavir—Malnutrition—Topiramate—epilepsy syndrome	1.84e-05	0.000125	CcSEcCtD
Saquinavir—Erythema—Topiramate—epilepsy syndrome	1.84e-05	0.000125	CcSEcCtD
Saquinavir—Discomfort—Gabapentin—epilepsy syndrome	1.84e-05	0.000125	CcSEcCtD
Saquinavir—Headache—Oxcarbazepine—epilepsy syndrome	1.83e-05	0.000124	CcSEcCtD
Saquinavir—Nausea—Zonisamide—epilepsy syndrome	1.82e-05	0.000124	CcSEcCtD
Saquinavir—Dry mouth—Gabapentin—epilepsy syndrome	1.82e-05	0.000123	CcSEcCtD
Saquinavir—Hypotension—Pregabalin—epilepsy syndrome	1.82e-05	0.000123	CcSEcCtD
Saquinavir—ABCB1—brain—epilepsy syndrome	1.81e-05	0.00461	CbGeAlD
Saquinavir—Flatulence—Topiramate—epilepsy syndrome	1.81e-05	0.000123	CcSEcCtD
Saquinavir—Dysgeusia—Topiramate—epilepsy syndrome	1.8e-05	0.000122	CcSEcCtD
Saquinavir—Confusional state—Gabapentin—epilepsy syndrome	1.8e-05	0.000122	CcSEcCtD
Saquinavir—Dizziness—Lamotrigine—epilepsy syndrome	1.79e-05	0.000121	CcSEcCtD
Saquinavir—Oedema—Gabapentin—epilepsy syndrome	1.79e-05	0.000121	CcSEcCtD
Saquinavir—Vomiting—Carbamazepine—epilepsy syndrome	1.78e-05	0.000121	CcSEcCtD
Saquinavir—Back pain—Topiramate—epilepsy syndrome	1.78e-05	0.000121	CcSEcCtD
Saquinavir—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.77e-05	0.00012	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.77e-05	0.00012	CcSEcCtD
Saquinavir—Infection—Gabapentin—epilepsy syndrome	1.77e-05	0.00012	CcSEcCtD
Saquinavir—Muscle spasms—Topiramate—epilepsy syndrome	1.77e-05	0.00012	CcSEcCtD
Saquinavir—Rash—Carbamazepine—epilepsy syndrome	1.77e-05	0.00012	CcSEcCtD
Saquinavir—Dermatitis—Carbamazepine—epilepsy syndrome	1.77e-05	0.00012	CcSEcCtD
Saquinavir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.76e-05	0.000119	CcSEcCtD
Saquinavir—Insomnia—Pregabalin—epilepsy syndrome	1.76e-05	0.000119	CcSEcCtD
Saquinavir—Nausea—Clonazepam—epilepsy syndrome	1.76e-05	0.000119	CcSEcCtD
Saquinavir—Headache—Carbamazepine—epilepsy syndrome	1.76e-05	0.000119	CcSEcCtD
Saquinavir—Shock—Gabapentin—epilepsy syndrome	1.76e-05	0.000119	CcSEcCtD
Saquinavir—Nervous system disorder—Gabapentin—epilepsy syndrome	1.75e-05	0.000119	CcSEcCtD
Saquinavir—Paraesthesia—Pregabalin—epilepsy syndrome	1.75e-05	0.000118	CcSEcCtD
Saquinavir—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.75e-05	0.000118	CcSEcCtD
Saquinavir—Nausea—Phenytoin—epilepsy syndrome	1.74e-05	0.000118	CcSEcCtD
Saquinavir—Dyspnoea—Pregabalin—epilepsy syndrome	1.74e-05	0.000118	CcSEcCtD
Saquinavir—Nausea—Oxcarbazepine—epilepsy syndrome	1.74e-05	0.000118	CcSEcCtD
Saquinavir—Skin disorder—Gabapentin—epilepsy syndrome	1.73e-05	0.000118	CcSEcCtD
Saquinavir—Somnolence—Pregabalin—epilepsy syndrome	1.73e-05	0.000117	CcSEcCtD
Saquinavir—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.73e-05	0.000117	CcSEcCtD
Saquinavir—Tremor—Topiramate—epilepsy syndrome	1.72e-05	0.000117	CcSEcCtD
Saquinavir—Vomiting—Lamotrigine—epilepsy syndrome	1.72e-05	0.000117	CcSEcCtD
Saquinavir—Urticaria—Valproic Acid—epilepsy syndrome	1.71e-05	0.000116	CcSEcCtD
Saquinavir—Rash—Lamotrigine—epilepsy syndrome	1.71e-05	0.000116	CcSEcCtD
Saquinavir—Ill-defined disorder—Topiramate—epilepsy syndrome	1.71e-05	0.000116	CcSEcCtD
Saquinavir—Dermatitis—Lamotrigine—epilepsy syndrome	1.71e-05	0.000116	CcSEcCtD
Saquinavir—Body temperature increased—Valproic Acid—epilepsy syndrome	1.7e-05	0.000115	CcSEcCtD
Saquinavir—Abdominal pain—Valproic Acid—epilepsy syndrome	1.7e-05	0.000115	CcSEcCtD
Saquinavir—Anorexia—Gabapentin—epilepsy syndrome	1.7e-05	0.000115	CcSEcCtD
Saquinavir—Anaemia—Topiramate—epilepsy syndrome	1.7e-05	0.000115	CcSEcCtD
Saquinavir—Headache—Lamotrigine—epilepsy syndrome	1.7e-05	0.000115	CcSEcCtD
Saquinavir—Decreased appetite—Pregabalin—epilepsy syndrome	1.69e-05	0.000115	CcSEcCtD
Saquinavir—Agitation—Topiramate—epilepsy syndrome	1.69e-05	0.000115	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.68e-05	0.000114	CcSEcCtD
Saquinavir—Fatigue—Pregabalin—epilepsy syndrome	1.68e-05	0.000114	CcSEcCtD
Saquinavir—Hypotension—Gabapentin—epilepsy syndrome	1.67e-05	0.000113	CcSEcCtD
Saquinavir—Nausea—Carbamazepine—epilepsy syndrome	1.67e-05	0.000113	CcSEcCtD
Saquinavir—Pain—Pregabalin—epilepsy syndrome	1.66e-05	0.000113	CcSEcCtD
Saquinavir—Constipation—Pregabalin—epilepsy syndrome	1.66e-05	0.000113	CcSEcCtD
Saquinavir—Malaise—Topiramate—epilepsy syndrome	1.66e-05	0.000112	CcSEcCtD
Saquinavir—Vertigo—Topiramate—epilepsy syndrome	1.65e-05	0.000112	CcSEcCtD
Saquinavir—Syncope—Topiramate—epilepsy syndrome	1.65e-05	0.000112	CcSEcCtD
Saquinavir—Leukopenia—Topiramate—epilepsy syndrome	1.65e-05	0.000112	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.63e-05	0.00011	CcSEcCtD
Saquinavir—Loss of consciousness—Topiramate—epilepsy syndrome	1.62e-05	0.00011	CcSEcCtD
Saquinavir—Insomnia—Gabapentin—epilepsy syndrome	1.61e-05	0.000109	CcSEcCtD
Saquinavir—Nausea—Lamotrigine—epilepsy syndrome	1.61e-05	0.000109	CcSEcCtD
Saquinavir—Cough—Topiramate—epilepsy syndrome	1.61e-05	0.000109	CcSEcCtD
Saquinavir—Feeling abnormal—Pregabalin—epilepsy syndrome	1.6e-05	0.000109	CcSEcCtD
Saquinavir—Paraesthesia—Gabapentin—epilepsy syndrome	1.6e-05	0.000109	CcSEcCtD
Saquinavir—Convulsion—Topiramate—epilepsy syndrome	1.59e-05	0.000108	CcSEcCtD
Saquinavir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.59e-05	0.000108	CcSEcCtD
Saquinavir—Dyspnoea—Gabapentin—epilepsy syndrome	1.59e-05	0.000108	CcSEcCtD
Saquinavir—Hypertension—Topiramate—epilepsy syndrome	1.59e-05	0.000108	CcSEcCtD
Saquinavir—Somnolence—Gabapentin—epilepsy syndrome	1.59e-05	0.000108	CcSEcCtD
Saquinavir—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.59e-05	0.000108	CcSEcCtD
Saquinavir—Dyspepsia—Gabapentin—epilepsy syndrome	1.57e-05	0.000107	CcSEcCtD
Saquinavir—Arthralgia—Topiramate—epilepsy syndrome	1.57e-05	0.000106	CcSEcCtD
Saquinavir—Myalgia—Topiramate—epilepsy syndrome	1.57e-05	0.000106	CcSEcCtD
Saquinavir—Chest pain—Topiramate—epilepsy syndrome	1.57e-05	0.000106	CcSEcCtD
Saquinavir—Anxiety—Topiramate—epilepsy syndrome	1.56e-05	0.000106	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.56e-05	0.000105	CcSEcCtD
Saquinavir—Decreased appetite—Gabapentin—epilepsy syndrome	1.55e-05	0.000105	CcSEcCtD
Saquinavir—Discomfort—Topiramate—epilepsy syndrome	1.55e-05	0.000105	CcSEcCtD
Saquinavir—Urticaria—Pregabalin—epilepsy syndrome	1.55e-05	0.000105	CcSEcCtD
Saquinavir—Asthenia—Valproic Acid—epilepsy syndrome	1.54e-05	0.000105	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.54e-05	0.000104	CcSEcCtD
Saquinavir—Fatigue—Gabapentin—epilepsy syndrome	1.54e-05	0.000104	CcSEcCtD
Saquinavir—Abdominal pain—Pregabalin—epilepsy syndrome	1.54e-05	0.000104	CcSEcCtD
Saquinavir—Body temperature increased—Pregabalin—epilepsy syndrome	1.54e-05	0.000104	CcSEcCtD
Saquinavir—Dry mouth—Topiramate—epilepsy syndrome	1.53e-05	0.000104	CcSEcCtD
Saquinavir—Pain—Gabapentin—epilepsy syndrome	1.53e-05	0.000103	CcSEcCtD
Saquinavir—Constipation—Gabapentin—epilepsy syndrome	1.53e-05	0.000103	CcSEcCtD
Saquinavir—Pruritus—Valproic Acid—epilepsy syndrome	1.52e-05	0.000103	CcSEcCtD
Saquinavir—Confusional state—Topiramate—epilepsy syndrome	1.51e-05	0.000103	CcSEcCtD
Saquinavir—Oedema—Topiramate—epilepsy syndrome	1.5e-05	0.000102	CcSEcCtD
Saquinavir—Infection—Topiramate—epilepsy syndrome	1.49e-05	0.000101	CcSEcCtD
Saquinavir—Shock—Topiramate—epilepsy syndrome	1.48e-05	0.0001	CcSEcCtD
Saquinavir—Diarrhoea—Valproic Acid—epilepsy syndrome	1.47e-05	9.99e-05	CcSEcCtD
Saquinavir—Nervous system disorder—Topiramate—epilepsy syndrome	1.47e-05	9.98e-05	CcSEcCtD
Saquinavir—Feeling abnormal—Gabapentin—epilepsy syndrome	1.47e-05	9.97e-05	CcSEcCtD
Saquinavir—Thrombocytopenia—Topiramate—epilepsy syndrome	1.47e-05	9.97e-05	CcSEcCtD
Saquinavir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.46e-05	9.89e-05	CcSEcCtD
Saquinavir—Skin disorder—Topiramate—epilepsy syndrome	1.46e-05	9.89e-05	CcSEcCtD
Saquinavir—Hyperhidrosis—Topiramate—epilepsy syndrome	1.45e-05	9.84e-05	CcSEcCtD
Saquinavir—Hypersensitivity—Pregabalin—epilepsy syndrome	1.43e-05	9.72e-05	CcSEcCtD
Saquinavir—Anorexia—Topiramate—epilepsy syndrome	1.43e-05	9.7e-05	CcSEcCtD
Saquinavir—Dizziness—Valproic Acid—epilepsy syndrome	1.42e-05	9.65e-05	CcSEcCtD
Saquinavir—Urticaria—Gabapentin—epilepsy syndrome	1.42e-05	9.61e-05	CcSEcCtD
Saquinavir—Abdominal pain—Gabapentin—epilepsy syndrome	1.41e-05	9.57e-05	CcSEcCtD
Saquinavir—Body temperature increased—Gabapentin—epilepsy syndrome	1.41e-05	9.57e-05	CcSEcCtD
Saquinavir—Hypotension—Topiramate—epilepsy syndrome	1.4e-05	9.51e-05	CcSEcCtD
Saquinavir—Asthenia—Pregabalin—epilepsy syndrome	1.4e-05	9.47e-05	CcSEcCtD
Saquinavir—Pruritus—Pregabalin—epilepsy syndrome	1.38e-05	9.34e-05	CcSEcCtD
Saquinavir—Vomiting—Valproic Acid—epilepsy syndrome	1.37e-05	9.28e-05	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.37e-05	9.28e-05	CcSEcCtD
Saquinavir—Insomnia—Topiramate—epilepsy syndrome	1.36e-05	9.21e-05	CcSEcCtD
Saquinavir—Rash—Valproic Acid—epilepsy syndrome	1.36e-05	9.2e-05	CcSEcCtD
Saquinavir—Dermatitis—Valproic Acid—epilepsy syndrome	1.36e-05	9.19e-05	CcSEcCtD
Saquinavir—Headache—Valproic Acid—epilepsy syndrome	1.35e-05	9.14e-05	CcSEcCtD
Saquinavir—Paraesthesia—Topiramate—epilepsy syndrome	1.35e-05	9.14e-05	CcSEcCtD
Saquinavir—Dyspnoea—Topiramate—epilepsy syndrome	1.34e-05	9.08e-05	CcSEcCtD
Saquinavir—Somnolence—Topiramate—epilepsy syndrome	1.34e-05	9.05e-05	CcSEcCtD
Saquinavir—Diarrhoea—Pregabalin—epilepsy syndrome	1.33e-05	9.03e-05	CcSEcCtD
Saquinavir—Dyspepsia—Topiramate—epilepsy syndrome	1.32e-05	8.96e-05	CcSEcCtD
Saquinavir—Hypersensitivity—Gabapentin—epilepsy syndrome	1.32e-05	8.92e-05	CcSEcCtD
Saquinavir—Decreased appetite—Topiramate—epilepsy syndrome	1.31e-05	8.85e-05	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.3e-05	8.79e-05	CcSEcCtD
Saquinavir—Fatigue—Topiramate—epilepsy syndrome	1.29e-05	8.78e-05	CcSEcCtD
Saquinavir—Dizziness—Pregabalin—epilepsy syndrome	1.29e-05	8.73e-05	CcSEcCtD
Saquinavir—Pain—Topiramate—epilepsy syndrome	1.28e-05	8.71e-05	CcSEcCtD
Saquinavir—Constipation—Topiramate—epilepsy syndrome	1.28e-05	8.71e-05	CcSEcCtD
Saquinavir—Asthenia—Gabapentin—epilepsy syndrome	1.28e-05	8.68e-05	CcSEcCtD
Saquinavir—Nausea—Valproic Acid—epilepsy syndrome	1.28e-05	8.67e-05	CcSEcCtD
Saquinavir—Pruritus—Gabapentin—epilepsy syndrome	1.26e-05	8.56e-05	CcSEcCtD
Saquinavir—Vomiting—Pregabalin—epilepsy syndrome	1.24e-05	8.39e-05	CcSEcCtD
Saquinavir—Feeling abnormal—Topiramate—epilepsy syndrome	1.24e-05	8.39e-05	CcSEcCtD
Saquinavir—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.23e-05	8.32e-05	CcSEcCtD
Saquinavir—Rash—Pregabalin—epilepsy syndrome	1.23e-05	8.32e-05	CcSEcCtD
Saquinavir—Dermatitis—Pregabalin—epilepsy syndrome	1.23e-05	8.31e-05	CcSEcCtD
Saquinavir—Diarrhoea—Gabapentin—epilepsy syndrome	1.22e-05	8.28e-05	CcSEcCtD
Saquinavir—Headache—Pregabalin—epilepsy syndrome	1.22e-05	8.27e-05	CcSEcCtD
Saquinavir—Urticaria—Topiramate—epilepsy syndrome	1.19e-05	8.09e-05	CcSEcCtD
Saquinavir—Body temperature increased—Topiramate—epilepsy syndrome	1.19e-05	8.05e-05	CcSEcCtD
Saquinavir—Abdominal pain—Topiramate—epilepsy syndrome	1.19e-05	8.05e-05	CcSEcCtD
Saquinavir—Dizziness—Gabapentin—epilepsy syndrome	1.18e-05	8e-05	CcSEcCtD
Saquinavir—Nausea—Pregabalin—epilepsy syndrome	1.16e-05	7.84e-05	CcSEcCtD
Saquinavir—Vomiting—Gabapentin—epilepsy syndrome	1.13e-05	7.69e-05	CcSEcCtD
Saquinavir—Rash—Gabapentin—epilepsy syndrome	1.13e-05	7.63e-05	CcSEcCtD
Saquinavir—Dermatitis—Gabapentin—epilepsy syndrome	1.12e-05	7.62e-05	CcSEcCtD
Saquinavir—Headache—Gabapentin—epilepsy syndrome	1.12e-05	7.58e-05	CcSEcCtD
Saquinavir—Hypersensitivity—Topiramate—epilepsy syndrome	1.11e-05	7.5e-05	CcSEcCtD
Saquinavir—Asthenia—Topiramate—epilepsy syndrome	1.08e-05	7.3e-05	CcSEcCtD
Saquinavir—Pruritus—Topiramate—epilepsy syndrome	1.06e-05	7.2e-05	CcSEcCtD
Saquinavir—Nausea—Gabapentin—epilepsy syndrome	1.06e-05	7.19e-05	CcSEcCtD
Saquinavir—Diarrhoea—Topiramate—epilepsy syndrome	1.03e-05	6.97e-05	CcSEcCtD
Saquinavir—Dizziness—Topiramate—epilepsy syndrome	9.93e-06	6.73e-05	CcSEcCtD
Saquinavir—Vomiting—Topiramate—epilepsy syndrome	9.55e-06	6.47e-05	CcSEcCtD
Saquinavir—Rash—Topiramate—epilepsy syndrome	9.47e-06	6.42e-05	CcSEcCtD
Saquinavir—Dermatitis—Topiramate—epilepsy syndrome	9.46e-06	6.41e-05	CcSEcCtD
Saquinavir—Headache—Topiramate—epilepsy syndrome	9.41e-06	6.38e-05	CcSEcCtD
Saquinavir—Nausea—Topiramate—epilepsy syndrome	8.92e-06	6.05e-05	CcSEcCtD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.21e-06	6.12e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—CHRM3—epilepsy syndrome	3.17e-06	6.05e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	3.17e-06	6.05e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—GPX1—epilepsy syndrome	3.15e-06	6.02e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.15e-06	6.01e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.14e-06	5.99e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—HMOX1—epilepsy syndrome	3.11e-06	5.94e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	3.08e-06	5.88e-05	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—AGT—epilepsy syndrome	3.07e-06	5.87e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—CAT—epilepsy syndrome	3.07e-06	5.86e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—CAT—epilepsy syndrome	3.04e-06	5.81e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—IL6ST—epilepsy syndrome	3.04e-06	5.8e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.03e-06	5.79e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.03e-06	5.79e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.03e-06	5.78e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—NOS2—epilepsy syndrome	3.01e-06	5.75e-05	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—APOE—epilepsy syndrome	3.01e-06	5.75e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	3e-06	5.72e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	2.99e-06	5.72e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	2.99e-06	5.71e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	2.99e-06	5.71e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—ABCB1—epilepsy syndrome	2.98e-06	5.7e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	2.97e-06	5.67e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.96e-06	5.66e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	2.96e-06	5.66e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	2.96e-06	5.66e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	2.96e-06	5.65e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—ABCG2—epilepsy syndrome	2.95e-06	5.63e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	2.89e-06	5.52e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—CYP2C19—epilepsy syndrome	2.88e-06	5.49e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	2.87e-06	5.49e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—HMOX1—epilepsy syndrome	2.87e-06	5.48e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—CYP11A1—epilepsy syndrome	2.86e-06	5.46e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.85e-06	5.45e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.85e-06	5.44e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	2.85e-06	5.44e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—BCHE—epilepsy syndrome	2.84e-06	5.42e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.84e-06	5.42e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—CAT—epilepsy syndrome	2.83e-06	5.4e-05	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—PTGS2—epilepsy syndrome	2.81e-06	5.37e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—GPX1—epilepsy syndrome	2.77e-06	5.3e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.77e-06	5.29e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—AGT—epilepsy syndrome	2.76e-06	5.28e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.76e-06	5.27e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—ABCB1—epilepsy syndrome	2.75e-06	5.26e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—GPX1—epilepsy syndrome	2.75e-06	5.25e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—APOE—epilepsy syndrome	2.71e-06	5.17e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	2.71e-06	5.17e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.7e-06	5.16e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.7e-06	5.16e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.7e-06	5.16e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.68e-06	5.11e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—TH—epilepsy syndrome	2.67e-06	5.1e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	2.65e-06	5.06e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—AGT—epilepsy syndrome	2.63e-06	5.02e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.6e-06	4.97e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	2.59e-06	4.95e-05	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—POMC—epilepsy syndrome	2.59e-06	4.94e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—ABCG2—epilepsy syndrome	2.58e-06	4.94e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—CYP2D6—epilepsy syndrome	2.58e-06	4.92e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.58e-06	4.92e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.58e-06	4.92e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—APOE—epilepsy syndrome	2.57e-06	4.91e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	2.56e-06	4.9e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—GPX1—epilepsy syndrome	2.56e-06	4.89e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.55e-06	4.86e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.52e-06	4.82e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	2.52e-06	4.81e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.5e-06	4.78e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.47e-06	4.72e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	2.47e-06	4.71e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—BCHE—epilepsy syndrome	2.46e-06	4.69e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—FGF2—epilepsy syndrome	2.46e-06	4.69e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—ADRA2A—epilepsy syndrome	2.45e-06	4.69e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—BCHE—epilepsy syndrome	2.44e-06	4.67e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.44e-06	4.65e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—AGT—epilepsy syndrome	2.43e-06	4.64e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.42e-06	4.63e-05	CbGpPWpGaD
Saquinavir—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	2.42e-06	4.63e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.41e-06	4.61e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—AGT—epilepsy syndrome	2.41e-06	4.6e-05	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.39e-06	4.56e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—APOE—epilepsy syndrome	2.38e-06	4.55e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.38e-06	4.54e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.37e-06	4.53e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—APOE—epilepsy syndrome	2.36e-06	4.51e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.36e-06	4.5e-05	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—ALB—epilepsy syndrome	2.36e-06	4.5e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.35e-06	4.49e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	2.35e-06	4.48e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.34e-06	4.47e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—SLC2A1—epilepsy syndrome	2.33e-06	4.45e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—POMC—epilepsy syndrome	2.33e-06	4.44e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.32e-06	4.43e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.32e-06	4.43e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	2.32e-06	4.43e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.31e-06	4.42e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—TH—epilepsy syndrome	2.31e-06	4.41e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PLCB1—epilepsy syndrome	2.31e-06	4.4e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—TH—epilepsy syndrome	2.3e-06	4.39e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.28e-06	4.35e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.26e-06	4.32e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.26e-06	4.31e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—AGT—epilepsy syndrome	2.24e-06	4.28e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—MTOR—epilepsy syndrome	2.24e-06	4.27e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.23e-06	4.25e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.23e-06	4.25e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—PTGS2—epilepsy syndrome	2.22e-06	4.23e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—POMC—epilepsy syndrome	2.21e-06	4.22e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.2e-06	4.21e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—APOE—epilepsy syndrome	2.2e-06	4.2e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.2e-06	4.2e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.19e-06	4.19e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.16e-06	4.12e-05	CbGpPWpGaD
Saquinavir—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.15e-06	4.11e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.15e-06	4.11e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.14e-06	4.09e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2.14e-06	4.08e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—ALB—epilepsy syndrome	2.12e-06	4.05e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.12e-06	4.04e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.11e-06	4.03e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	2.09e-06	4e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	2.07e-06	3.95e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—TH—epilepsy syndrome	2.06e-06	3.94e-05	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PTGS2—epilepsy syndrome	2.06e-06	3.94e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—POMC—epilepsy syndrome	2.05e-06	3.91e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.04e-06	3.9e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.03e-06	3.88e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—POMC—epilepsy syndrome	2.03e-06	3.87e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.03e-06	3.87e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.02e-06	3.86e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.02e-06	3.85e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—ALB—epilepsy syndrome	2.02e-06	3.85e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—TH—epilepsy syndrome	2.01e-06	3.85e-05	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—SRC—epilepsy syndrome	2.01e-06	3.84e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.01e-06	3.84e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2e-06	3.82e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.99e-06	3.8e-05	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—VEGFA—epilepsy syndrome	1.96e-06	3.74e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.95e-06	3.73e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.95e-06	3.73e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.93e-06	3.68e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.93e-06	3.68e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—HMOX1—epilepsy syndrome	1.92e-06	3.66e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.91e-06	3.64e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.9e-06	3.64e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.9e-06	3.63e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—TH—epilepsy syndrome	1.9e-06	3.62e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—CAT—epilepsy syndrome	1.89e-06	3.61e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—POMC—epilepsy syndrome	1.89e-06	3.61e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.89e-06	3.61e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—TH—epilepsy syndrome	1.88e-06	3.59e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—ALB—epilepsy syndrome	1.87e-06	3.56e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PTGS2—epilepsy syndrome	1.86e-06	3.54e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.85e-06	3.54e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.85e-06	3.54e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.85e-06	3.53e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—ABCB1—epilepsy syndrome	1.84e-06	3.52e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—SRC—epilepsy syndrome	1.79e-06	3.42e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	1.76e-06	3.37e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.74e-06	3.33e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.72e-06	3.29e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—ALB—epilepsy syndrome	1.72e-06	3.29e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.72e-06	3.29e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—GPX1—epilepsy syndrome	1.71e-06	3.27e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.71e-06	3.26e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.7e-06	3.24e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.68e-06	3.21e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—CAT—epilepsy syndrome	1.66e-06	3.17e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.65e-06	3.16e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PTGS2—epilepsy syndrome	1.63e-06	3.12e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.62e-06	3.09e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.59e-06	3.04e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.58e-06	3.02e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.57e-06	3e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.56e-06	2.98e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.55e-06	2.96e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.55e-06	2.96e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.54e-06	2.95e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.54e-06	2.93e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.52e-06	2.9e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.51e-06	2.88e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.51e-06	2.88e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	1.51e-06	2.88e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—AGT—epilepsy syndrome	1.5e-06	2.87e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.5e-06	2.86e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.48e-06	2.82e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—APOE—epilepsy syndrome	1.47e-06	2.81e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.47e-06	2.8e-05	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—AKT1—epilepsy syndrome	1.41e-06	2.7e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.41e-06	2.7e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.4e-06	2.68e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.39e-06	2.66e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.35e-06	2.57e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.34e-06	2.55e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.33e-06	2.53e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.32e-06	2.52e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.32e-06	2.52e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—AGT—epilepsy syndrome	1.32e-06	2.51e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—APOE—epilepsy syndrome	1.29e-06	2.46e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.27e-06	2.43e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—POMC—epilepsy syndrome	1.26e-06	2.41e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.26e-06	2.4e-05	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—AKT1—epilepsy syndrome	1.25e-06	2.39e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.25e-06	2.38e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—TH—epilepsy syndrome	1.24e-06	2.37e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.24e-06	2.37e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.23e-06	2.35e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.21e-06	2.32e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.2e-06	2.3e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.17e-06	2.23e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.16e-06	2.21e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.13e-06	2.17e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—AKT1—epilepsy syndrome	1.11e-06	2.13e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—POMC—epilepsy syndrome	1.11e-06	2.11e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.04e-06	1.99e-05	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—AKT1—epilepsy syndrome	1.04e-06	1.98e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.04e-06	1.98e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.03e-06	1.97e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.03e-06	1.97e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.02e-06	1.95e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.01e-06	1.94e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—ALB—epilepsy syndrome	1.01e-06	1.93e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PTGS2—epilepsy syndrome	1.01e-06	1.92e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	9.94e-07	1.9e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—ALB—epilepsy syndrome	9.51e-07	1.82e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—ALB—epilepsy syndrome	9.43e-07	1.8e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—AKT1—epilepsy syndrome	9.33e-07	1.78e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GPX1—epilepsy syndrome	9.24e-07	1.76e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	9.05e-07	1.73e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	8.86e-07	1.69e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PTGS2—epilepsy syndrome	8.83e-07	1.69e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	8.32e-07	1.59e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	8.25e-07	1.57e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—AKT1—epilepsy syndrome	8.21e-07	1.57e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—AKT1—epilepsy syndrome	8.14e-07	1.55e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—AGT—epilepsy syndrome	8.1e-07	1.55e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—APOE—epilepsy syndrome	7.94e-07	1.52e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—AKT1—epilepsy syndrome	7.57e-07	1.45e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.82e-07	1.3e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.22e-07	1.19e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—AKT1—epilepsy syndrome	5.88e-07	1.12e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.44e-07	1.04e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—AKT1—epilepsy syndrome	5.09e-07	9.73e-06	CbGpPWpGaD
Saquinavir—ALB—Metabolism—AKT1—epilepsy syndrome	5.06e-07	9.67e-06	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—AKT1—epilepsy syndrome	4.55e-07	8.68e-06	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—AKT1—epilepsy syndrome	4.44e-07	8.47e-06	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—AKT1—epilepsy syndrome	4.18e-07	7.98e-06	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—AKT1—epilepsy syndrome	4.15e-07	7.92e-06	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.73e-07	5.22e-06	CbGpPWpGaD
